TYMPIC: Wideband Tympanometry for Monitoring Intracranial Pressure in Adult Patients in Intensive Care, Operated on for an Intracranial Lesion After Traumatic Brain Injury, or With Intracranial Hemorrhage

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Recruiting
CT.gov ID
NCT04849221
Collaborator
(none)
25
1
16.9
1.5

Study Details

Study Description

Brief Summary

Intracranial pressure is usually measured by invasive methods requiring an intracranial sensor. There is no non-invasive monitoring method recognized as a gold standard. Tympanometry would make it feasible to evaluate intracranial pressure through sensitive and specific changes in the energy absorbance of the middle ear. It could represent a non-invasive method of monitoring intracranial pressure.

This is a prospective monocentric longitudinal study. All adult patients in intensive care for head trauma, intracranial hypertension, or after cranial surgery and requiring invasive monitoring of ICP will be included after their non-opposition has been collected.

In a group of 10 controls, multifrequency tympanometry will be performed in the standing position, in the 0° supine position and in the Tredelenburg position at -17°.

Condition or Disease Intervention/Treatment Phase
  • Other: Tympanometry measurement in both ears
  • Other: Collection of clinical and paraclinical data
  • Other: Intracranial pressure reading (ICP)

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Wideband Tympanometry for Monitoring Intracranial Pressure in Adult Patients in Intensive Care, Operated on for an Intracranial Lesion After Traumatic Brain Injury, or With Intracranial Hemorrhage
Actual Study Start Date :
Mar 4, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients

Head trauma, patient operated on for an intracranial lesion, or other condition (hemorrhagic stroke)

Other: Tympanometry measurement in both ears
Measurement once or twice a day and at every change of more than 10 mmHg in ICP, over the entire period of time that ICP is measured by a probe or DVE

Other: Collection of clinical and paraclinical data
Patient: gender, weight/height, age, etiology of ICP entry, reason for ICP monitoring, presence of external (otoscopy), middle (otoscopy + CT) or internal (CT) ear abnormality, presence of inclusion and non-inclusion criteria, measurement of patient tilt. healthy subjects: gender, weight/height, age, presence of abnormality of the external (otoscopy), middle (otoscopy) or internal ear (questioning), presence of inclusion and non-inclusion criteria...

Other: Intracranial pressure reading (ICP)
a single measure

healthy subjects

No otologic or neurological history

Other: Collection of clinical and paraclinical data
Patient: gender, weight/height, age, etiology of ICP entry, reason for ICP monitoring, presence of external (otoscopy), middle (otoscopy + CT) or internal (CT) ear abnormality, presence of inclusion and non-inclusion criteria, measurement of patient tilt. healthy subjects: gender, weight/height, age, presence of abnormality of the external (otoscopy), middle (otoscopy) or internal ear (questioning), presence of inclusion and non-inclusion criteria...

Other: Intracranial pressure reading (ICP)
a single measure

Outcome Measures

Primary Outcome Measures

  1. Volume of the ear canal as a function of intracranial pressure [Approximately on the 10th day]

  2. Width between conductance peaks of tympanometry at 2kHz as a function of intracranial pressure [Approximately on the 10th day]

  3. Middle ear resonance frequency as a function of intracranial pressure [Approximately on the 10th day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Patients:
  • Person who did not oppose to their inclusion in the trial

  • Head trauma, patient operated on for an intracranial lesion, or other condition (hemorrhagic stroke...) requiring monitoring of ICP by a subdural or epidural sensor.

  • Age > 18 years old

Controls:
  • Person who did not oppose to their inclusion in the trial

  • Age > 18 years old

  • No otologic or neurological history.

Exclusion Criteria:
  • Person subject to a measure of legal protection (curatorship, guardianship)

  • Person under judicial control

  • Pregnant, parturient or breastfeeding woman

  • Minor

  • Fracture of the petrosal bone, abnormality of the bilateral middle or inner ear or canal preventing tympanometry

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Dijon Bourogne Dijon France 21000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT04849221
Other Study ID Numbers:
  • BOZORG NOURRISSON 2020
First Posted:
Apr 19, 2021
Last Update Posted:
Mar 15, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2022